| 
The
intention to create the ProCura network started in the beginning
of 2001, when the research group, Grupo de Investigação
em Fibrose Quística, Centro de Genética Humana, Instituto
Nacional de Saúde Dr Ricardo Jorge (coordinated by Deborah
Penque and Margarida Amaral) invited two others, Laboratório
de Química, Universidade de Aveiro (coordinated by Ferrer
Correia and represented by Francisco Amado and Pedro Domingues)
and Unidade de Bioinformática, Instituto Gulbenkian de Ciência
(coordinated by Pedro Fernandes) to join in a collaborative proteomics
research project.
ProCura is conducting now a survey of existing proteomics efforts
in Portugal. The aim is to bring together Portuguese laboratories
to form a collaborative platform on the functional proteomics technology.
Each participating laboratory will have the opportunity to share
and use the benefits of proteomics to develop its own basic research
programs in different areas, such as molecular and cell biology,
biochemistry, biophysics, bioinformatics and clinical research.
ProCura-
Research Institution Members
ProCura-University
Members
Departament
of Chemistry, University of Aveiro
ProCura- Research Institution Members
Laboratório
de Proteómica
Centro de Genética Humana
Instituto Nacional de Saúde Dr Ricardo Jorge (CGH/INSA)
1649-016 Lisboa Portugal
Missions
- Developing an innovative proteomics technical
platform to the diagnosis, prognosis and assessment of infectious
and degenerative chronic diseases.
- Developing a integrate researcher for the elucidation of diseases,
namely, the chronic lung diseases [cystic, fibrosis, asthma, chronic
obstructive pulmonary disease (COPD)] and cancer disease (lung and
liver cancers), as well as to the identification of new biomarkers
and/or therapeutic targets. The ultimate goal is to provide the
INSA with new diagnostic and prognostic tools based on proteomics
allowing clinicians to truly tailor therapy.
- Contributing to the proteomics dissemination and application in
our country, trough the promotion of courses, laboratory trainings,
conferences and national and international networking.
Current Projects
2005-2006 Proteomics of Chronic Lung Diseases:
Leading to Biomarkers and Therapeutic Target Discovery.
Project suportted by Fundação da Ciência e a
Tecnologia (FCT) (POCTI/SAU-MMO/56163/2004).
Principal Investigator: D Penque, LP/CGH-INSA
2002- 2006 Proteome Analysis of Cystic Fibrosis
Transgenic Mice.
Project suportted by Fundação da Ciência e a
Tecnologia (POCTI/ESP/44720/2002).
Principal Investigator: D Penque, LP/CGH-INSA
2006-2007 Is the MicroRNA-122 specific determinant
for HCV virus replication in the chronic liver hepatitis?
Project rewarded in 2006 with a research grant of Associação
Portuguesa para o Estudo do Fígado (sponsored by Roche-Portugal
Lda).
Coordinator of the projecto: Jorge Peneda, UA/CBP-INSA.
Principal Investigator Principal: D Penque, LP/CGH-NSA.
2007- 2008 Autoimmunity in Behçet's
Disease - a Proteomics Approach.
Project suportted by Instituto Nacional de Saúde Dr. Ricardo
Jorge (BIC/07/2004-IV).
Principal Investigator: L Costa, UIDI/CBP-INSA / D Penque, LP/CGH-INSA
Team
Deborah
Penque, Reseacher Lab Coordinator 
Mª Fátima
Vaz, Principal Assistant of Technical Healthy Career
Lab Technical Responsible
Tânia
Simões, Post-Doctoral Fellow (FCT* )
Isabel
Carvalho-Oliveira, Doctoral Fellow (FCT*)
Patrícia
Gomes Alves, Doctoral Fellow (FCT*)
Bruno
M. Alexandre, Doctoral Fellow (FCT*)
Nuno Miguel
Charro, Doctoral Fellow (FCT*)
Judite Marques Dias,
Doctoral Fellow (FCT*)
João Banha,
Research Fellow INSA
Sofia Neves,
Research Fellow APEF**
*Fundação da Ciência e a Tecnologia;
**Associação Portuguesa para o Estudo do Fígado
Top
Group
of Hemoglobinopaties (Hb)
Centro de Genética Humana
Instituto Nacional de Saúde Dr Ricardo Jorge (CGH/INSA)
1649-016 Lisboa Portugal

For
the last ten years, this group has been actively involved in studying
the molecular basis of alfa- and ß-thalassemia in the Portuguese
population, by investigating a number of genetic alterations associated
with hemoglobin disorders, both at the genomic and functional levels.
Presently, our studies are specifically focused on the role of mRNA
stability in the control of human globin gene expression. In this
context, we are developing the following projects:
1. The study of the mechanism by which human normal ß-globin
mRNA is stabilized in erythroid cells.
2. The study of the human ß-globin mRNA nonsense-mediated
decay mechanism.
3. The study of the human alfa-globin mRNA nonsense-mediated decay
mechanism.
4. The suppression of premature stop codons in the human ß-globin
gene induced by pharmacological treatment.
Responsible: Luisa Romão
Top
Instituto Gulbenkian de Ciência (UB/IGC) - Unidade
de Bioinformática
 
The
operating team of this Unit is responsible for the Portuguese node
of the EMBnet for the last ten years, delivering to many users a
service that consists of providing access to periodically updated
copies of about 30 databases of sequence data, a suite of correctly
installed and documented programs to process them and user support
via e-mail or telephone. Specific bridging competence in the genomics/proteomics
area is presently one of the major targets of the current investments
in both tools and human expertise. The ProCura network is expected
to bring in some of the most challenging opportunities to field
test and deploy such facilities in full contact with the user community.
Responsible: Pedro Fernandes
Top
Instituto
de Biologia Molecular e Celular do Porto (IBMC) - Departamento de
Neurobiologia Molecular

Molecular Neurobiology
Basic and Clinical Neurobiology
Group Leader: Maria João Saraiva , PhD (Biomedical Inst.
U.P.)
Principal Investigators:
MR Almeida, PhD (Biomedical Inst. U.P.)
JA Palha, PhD (Health Sc, University of Braga, Adjunct Investigator)
MM Sousa, PhD (IBMC, U.P.)
This unit had its origins in 1997 with a background
on studies on familial amyloidotic polyneuropathy (FAP), a peculiar
form of neuropathy first described by the eminent Portuguese neurologist
Corino de Andrade, which is characterized by the deposition of amyloid
in special on the peripheral nerves. This autosomal dominant disease
is a health problem in the country. The unit is devoted to laboratorial
investigation on FAP on epidemiological, biochemical, genetic and
pathological aspects, as well as on the biology of transthyretin-
TTR (represented in the figure), a serum protein that when mutated
is the major defect underlying FAP.
The main objective of the team are the identification and characterization
of ethio-physiopathological mechanisms of FAP and the search for
preventive, diagnostic and treatment forms. The technologies developed
for these purposes are used, however, in studies of other TTR related
disorders, in basic research of human physiology specially those
associated with transport of thyroid hormones and vitamin A, natural
ligands of TTR, and in general with TTR.
ITQB/IBET
- Mass Spectometry Laboratory

Coordinator: Ana Coelho, PhD (labms@itqb.unl.pt)
The
ITQB/IBET Mass Spectrometry Laboratory performs internal and
external services and related research work. The laboratory installation
process started in October 2002 aiming to be certified as a GLP
unit. At the moment we perform mass determination, structural and
affinity studies for a broad range of chemical compounds, from small
organic and organometalic compounds to peptides, oligosacharides,
nucleotides and proteins. The information obtained with the powerful
mass spectrometry techniques is fundamental for the structural characterization
of chemical and biochemical species. Else than precise mass determination
it is possible to perform controlled fragmentation of the molecular
ions, which allows to get detailed structural information, like
comparative identification of organic compounds, peptide and oligosacharide
sequencing, characterization of post-translational modifications:
these are the so called MS/MS or tandem mass spectrometry experiments.
The mass spectrometry results are important, for example, in monitoring
chemical synthesis, purification and identification of chemical
and biochemical compounds, metabolic and kinetic studies.
Instrumentation
Thermofinnigan LCQ ion-trap coupled to an HPLC system with the
folowing ion sources:
- ESI (Electrospray Ionisation)
- APCI (Atmosferic Pressure Chemical Ionization)
Bruker Esquire 3000plus ion-trap with the folowing ion sources:
- ESI (Electrospray Ionisation)
- ESI (Nanoelectrospray)
- APCI (Atmosferic Pressure Chemical Ionization)
Applied Biosystem Voyager STR MALDI-TOF with reflectron
ITQB
Analytical Services
* Mass Spectrometry
* Protein
Sequencing
* Elemental
Analysis
* Amino
Acid Analysis
* Small Molecule X-ray Crystallography
Molecular Biology Laboratory
- Institute of Hygiene and Tropical Medicine
Rua da Junqueira, 96
1349-008 Lisboa Portugal
The Proteomics of Delta Hepatitis
The
Hepatitis delta virus (HDV) is the causative agent of one of the
most severe forms of virus hepatitis, being endemic in several regions
of the world. This virus is the smallest human pathogen known so
far. It's 1,7 Kb, circular, ss RNA genome – strikingly similar
to that of plant viroids -encodes for a single protein that is expressed
in two forms as a result of an RNA editing mechanism. Despite being
so simple, very little is known about the cellular factors involved
in virus replication and biogenesis as well as the pathogenic mechanisms
that may cause different disease forms: fulminant hepatitis, cirrhosis,
chronic hepatitis. In this project we intend to identify changes
in cellular gene expression at the protein level, that arise upon
HDV infection, and transient transfection of hepatoma cells with
cDNAs encoding the HDV components (RNA, and both forms of antigens).
Accomplishment of this goal will hopefully help to shad light on
the virus life cycle, and identify novel targets for a specific
therapy. Project coordinator: Celso Cunha; Molecular Biology Unit,
Institute of Hygiene and Tropical Medicine, Lisbon, Portugal (ccunha@ihmt.unl.pt)
Top

Rua da Junqueira, 96
1349-008 Lisboa
Tel: +351 213652657
Fax: +351 213622458
Missions
Malaria is a life threatening disease that kills
over a million each year. The parasite that causes it has a complex
life cycle involving a vertebrate host and a mosquito vector. Most
efforts have been put in controlling malaria in the vertebrate host.
Even so, an efficacious malaria vaccine is far from being achieved
and anti-malarial resistance have been spreading globally. Therefore,
complementary malaria control strategies acting on the vector are
urgently needed. Identification of mechanisms of infection control
and how they can be modulated will permit, in the long run, the
development of transmission blocking strategies. In this frame our
research is focused on the 1) influence of blood meal components
on the outcome of Plasmodium infection in the mosquito; and 2) characterization
of mosquito immune response to Plasmodium infection.
Using genomic approaches we established an undoubtful association
between chloroquine treatment and alterations in mosquito immune
response that may justify alterations in infectivity of Plasmodium
to the mosquito.
Our current aims are to 1) identify and characterize hemolymph proteins
that are involved in mosquito response to Plasmodium sporozoites;
2) Characterize serine proteases activity during Plasmodium infection
[in collaboration with Ana Domingos, INETI]. 3) characterize mosquito
immune molecules associate with parasite recognition using Lab and
field approaches.
Current
Projects
2003-2006 The effect of chloroquine
on the modulation of mosquito vector response to Plasmodium infection.
ref:POCTI/MGI/344905/2002
2006-2007 Gene variability
of pattern-recognition-molecules (PRM) involved in mosquito immune
response to Plasmodium. ref: POCI/SAU-IMI/59489/2004
Team
Henrique Silveira, Principal
Investigador
Susana Ramos,
PhD Student (FCT*)
Luis Filipe
Lopes, PhD Student (FCT*)
Patrícia
Abrantes, PhD Student (FCT*)
Rute Felix,
PhD Student (FCT*)
Bianor Valente,
MSc Student
* Fundação da Ciência
e a Tecnologia PhD fellowship
Top
ProCura-University
Members
Universidade de Aveiro
Departamento de Química
(DQ/UA)

Since
its firsts steps in 1975 of the Mass Spectrometer group at the University
of Aveiro the members of our lab are interested in a variety of
areas of mass spectrometry. Our focuses include research on the
gas phase ion chemistry and biological mass spectrometry. Research
projects are from the development of the application of ESI and
nano-ESI to Proteomics, Oxidative stress, Biogenic amines and Coordenation
compounds and to the fundamental studies of ion energetics.
Instrumentation
Q-TOF
II mass spectometer with the folowing ion sources:
- ESI (Electrospray Ionisation)
- ESI (Nanoelectrospray)
- APCI (Atmosferic Pressure Chemical Ionization)
Mass spectometer AUTOSPEQ (EBEqQ) with the folowing ion sources:
- ESI (Electrospray Ionisation)
- FAB (Fast Atom Bombardment)
- EI (Electronic Impact)
- CI (Chemical Ionization)
REQUIMTE
Laboratório Associado, CQFB, Departamento de Química
(FCT/UNL)


Departamento de Química
Faculdade de Ciências e Tecnologia
Universidade Nova de Lisboa
2829-516 Caparica, Portugal
Tel (office): +351 212 948 386; ext. 10907
Lab: +351 212 948 300; ext. 10972
Fax: +351 212 948 550
Missions
At Present the main research line of Dr. Capelo
belongs to analytical proteomics and metabolomics. Through drastic
changes introduced in the sample treatments for proteomics using
ultrasonication by Dr. Capelo´s research team, the standard
procedures for protein and peptide identification has been reduced
from days to seconds or few minutes. With the new ultra fast sample
treatments, the identification of virus and bacteria is done in
an easy and rapid manner, allowing rapid medical diagnosis for illnesses
and infections. At present the protocols already published by Dr.
Capelo are being used for the systematic identification of pathogens
(salmonella), in collaboration with some hospitals of the Lisbon
area. Furthermore, the simplification in the methodologies for the
analysis and identification of steroids in blood or urine (analytical
metabolomic) is a priority society´s demand in the fighting
against the fraud in sport. At present, new approaches for the fast
identification of steroids in urine are developed in the research
team of Dr.Capelo.
Current
Projects
Team
Dr. Jose Luis Capelo,
Researcher
Dr. Carlos Lodeiro, Researcher
Dr. Joao Paulo Noronha, Researcher
Dr. Raquel Rial, Researcher
Gonçalo Vale, Undergraduate Student
Hugo Santos, MSc student
Ricardo Carreira, PhD student
Marco Galesio, BSc
Cristiano Mota
Diana Vieira
Top
|